Generative Artificial Intelligence (AI) In Pharmaceutical Market Report 2026
Download Free Sample Buy Now
Generative Artificial Intelligence (AI) In Pharmaceutical Market Report Infographic Image

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Generative Artificial Intelligence (AI) In Pharmaceutical Market Report 2026

Global Outlook – By Type (Small Molecule, Large Molecule), By Technology (Deep Learning, Natural Language Processing, Querying Method, Context-Aware Processing, Other Technologies), By Application (Clinical Trial Research, Drug Discovery, Research And Development, Other Applications) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

• Generative Artificial Intelligence (AI) In Pharmaceutical market size has reached to $2.43 billion in 2025

• Expected to grow to $9.36 billion in 2030 at a compound annual growth rate (CAGR) of 30.9%

• Growth Driver: Rising Emphasis On Personalized Medicine Drive Generative AI in pharmaceutical Market

• Market Trend: Advancements In Drug Discovery With Generative AI

• North America was the largest region in 2025.

What Is Covered Under Generative Artificial Intelligence (AI) In Pharmaceutical Market?

Generative artificial intelligence (AI) in pharmaceuticals leverages advanced algorithms and machine learning to design new drug compounds, predict molecular behaviors, and optimize drug discovery processes. It uses techniques such as deep learning and generative adversarial networks (GANs) to create novel molecular structures and simulate their interactions.

The main types of generative artificial intelligence (AI) in pharmaceuticals are small molecules and large molecules. Small-molecule drugs are low-molecular-weight compounds that can easily enter cells and affect biological processes. The various technologies include deep learning, natural language processing, querying methods, context-aware processing, and others for varying applications such as clinical trial research, drug discovery, research and development, and others.

Generative Artificial Intelligence (AI) In Pharmaceutical market report bar graph

What Is The Generative Artificial Intelligence (AI) In Pharmaceutical Market Size and Share 2026?

The generative artificial intelligence (AI) in pharmaceutical market size has grown exponentially in recent years. It will grow from $2.43 billion in 2025 to $3.19 billion in 2026 at a compound annual growth rate (CAGR) of 31.2%. The growth in the historic period can be attributed to increasing r&d investments in pharmaceuticals, rise in chronic diseases, growing adoption of AI in early-stage drug discovery, expansion of biologics market, availability of large-scale molecular datasets.

What Is The Generative Artificial Intelligence (AI) In Pharmaceutical Market Growth Forecast?

The generative artificial intelligence (AI) in pharmaceutical market size is expected to see exponential growth in the next few years. It will grow to $9.36 billion in 2030 at a compound annual growth rate (CAGR) of 30.9%. The growth in the forecast period can be attributed to advancements in generative AI algorithms, growth of precision medicine, expansion of virtual clinical trials, rising demand for biologics optimization, integration of AI with cloud computing. Major trends in the forecast period include AI-driven drug design optimization, predictive molecular modeling, virtual screening of compound libraries, personalized medicine development, biopharmaceutical efficacy simulation.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Generative Artificial Intelligence (AI) In Pharmaceutical Market Segmentation

1) By Type: Small Molecule, Large Molecule

2) By Technology: Deep Learning, Natural Language Processing, Querying Method, Context-Aware Processing, Other Technologies

3) By Application: Clinical Trial Research, Drug Discovery, Research And Development, Other Applications

Subsegments:

1) By Small Molecule: Drug Discovery And Design, Lead Optimization For Small Molecule Compounds, Predictive Modeling For Pharmacokinetics And Toxicity, Virtual Screening Of Compound Libraries, Personalized Medicine Approaches For Small Molecule Therapies

2) By Large Molecule: Biologics Discovery And Development, Monoclonal Antibody Design, Protein Engineering And Optimization, Vaccine Development And Optimization, Predictive Models For Biopharmaceutical Efficacy And Safety.

What Is The Driver Of The Generative Artificial Intelligence (AI) In Pharmaceutical Market?

The increasing focus on personalized medicine is expected to propel the growth of generative artificial intelligence (AI) in the pharmaceutical market going forward. Personalized medicine tailors medical treatment to the individual characteristics, needs, and preferences of each patient based on genetic, environmental, and lifestyle factors. The focus on personalized medicine is increasing due to advancements in genetic research and technology, enabling more precise and effective treatments tailored to individual patients. Personalized medicine leverages generative AI in pharmaceuticals to develop tailored drug therapies, improving treatment efficacy and patient outcomes. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to six in 2022. Therefore, the increasing focus on personalized medicine is driving the growth of generative artificial intelligence (AI) in the pharmaceutical market.

Key Players In The Global Generative Artificial Intelligence (AI) In Pharmaceutical Market

Major companies operating in the generative artificial intelligence (AI) in pharmaceutical market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Fujitsu Limited, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., NVIDIA Corporation, Conduent Incorporated, XtalPi Inc., Insilico Medicine Inc., Numerate Inc., Atomwise Inc., BenevolentAI Limited

Global Generative Artificial Intelligence (AI) In Pharmaceutical Market Trends and Insights

Major companies operating in generative artificial intelligence (AI) in pharmaceutical market are developing new products, such as AI healthcare microservices, to streamline drug discovery processes. AI healthcare microservices are modular, cloud-based services that use artificial intelligence to improve healthcare functions such as drug discovery, medical imaging, and diagnostics. For instance, in March 2024, Nvidia Corporation, a US-based technology company, launched generative AI microservices. It features optimized NIM AI models and workflows with APIs for building cloud-native applications. It provides advanced imaging, natural language, and speech recognition, along with digital biology capabilities. The key tools included are Parabricks, MONAI, NeMo, Riva, and Metropolis are accessible as CUDA-X microservices, enhancing workflows in drug discovery and genomics.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Generative Artificial Intelligence (AI) In Pharmaceutical Market?

In June 2023, Eli Lilly and Company, a US-based company engaged in research-based pharmaceutical and biomedical research, collaborated with XtalPi Inc. The partnership will use XtalPi’s advanced AI-driven drug discovery platform, ID4Inno, to design and develop drug candidates targeting a specific, undisclosed goal. This collaboration aims to leverage XtalPi's technology to explore extensive chemical spaces and identify promising drug candidates through a process of iterative design, synthesis, testing, and analysis, all supported by autonomous robotic systems to ensure efficiency and precision. XtalPi Inc. is a China-based AI-powered drug research and development company.

Regional Insights

North America was the largest region in the generative artificial intelligence (AI) in the pharmaceutical market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Generative Artificial Intelligence (AI) In Pharmaceutical Market?

The generative artificial intelligence (AI) in pharmaceutical market includes revenues earned by entities through drug design, clinical trial optimization, biomarker discovery, and virtual screening. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Generative Artificial Intelligence (AI) In Pharmaceutical Market Report 2026?

The generative artificial intelligence (ai) in pharmaceutical market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the generative artificial intelligence (ai) in pharmaceutical industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Generative Artificial Intelligence (AI) In Pharmaceutical Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $3.19 billion
Revenue Forecast In 2035 $9.36 billion
Growth Rate CAGR of 31.2% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Technology, Application
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Fujitsu Limited, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., NVIDIA Corporation, Conduent Incorporated, XtalPi Inc., Insilico Medicine Inc., Numerate Inc., Atomwise Inc., BenevolentAI Limited
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Generative Artificial Intelligence (AI) In Pharmaceutical Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Generative Artificial Intelligence (AI) In Pharmaceutical Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Artificial Intelligence & Autonomous Intelligence

4.1.2 Biotechnology, Genomics & Precision Medicine

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Autonomous Systems, Robotics & Smart Mobility

4.2. Major Trends

4.2.1 AI-Driven Drug Design Optimization

4.2.2 Predictive Molecular Modeling

4.2.3 Virtual Screening Of Compound Libraries

4.2.4 Personalized Medicine Development

4.2.5 Biopharmaceutical Efficacy Simulation

5. Generative Artificial Intelligence (AI) In Pharmaceutical Market Analysis Of End Use Industries

5.1 Pharmaceutical Companies

5.2 Biotechnology Firms

5.3 Contract Research Organizations (Cros)

5.4 Academic & Research Institutions

5.5 Hospitals & Clinical Research Centers

6. Generative Artificial Intelligence (AI) In Pharmaceutical Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Generative Artificial Intelligence (AI) In Pharmaceutical Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Generative Artificial Intelligence (AI) In Pharmaceutical PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market Size, Comparisons And Growth Rate Analysis

7.3. Global Generative Artificial Intelligence (AI) In Pharmaceutical Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Generative Artificial Intelligence (AI) In Pharmaceutical Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Generative Artificial Intelligence (AI) In Pharmaceutical Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Generative Artificial Intelligence (AI) In Pharmaceutical Market Segmentation

9.1. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Small Molecule, Large Molecule

9.2. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Deep Learning, Natural Language Processing, Querying Method, Context-Aware Processing, Other Technologies

9.3. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Clinical Trial Research, Drug Discovery, Research And Development, Other Applications

9.4. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Sub-Segmentation Of Small Molecule, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Drug Discovery And Design, Lead Optimization For Small Molecule Compounds, Predictive Modeling For Pharmacokinetics And Toxicity, Virtual Screening Of Compound Libraries, Personalized Medicine Approaches For Small Molecule Therapies

9.5. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Sub-Segmentation Of Large Molecule, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Biologics Discovery And Development, Monoclonal Antibody Design, Protein Engineering And Optimization, Vaccine Development And Optimization, Predictive Models For Biopharmaceutical Efficacy And Safety

10. Generative Artificial Intelligence (AI) In Pharmaceutical Market, Industry Metrics By Country

10.1. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Average Selling Price By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $

10.2. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Average Spending Per Capita (Employed) By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $

11. Generative Artificial Intelligence (AI) In Pharmaceutical Market Regional And Country Analysis

11.1. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11.2. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. Asia-Pacific Generative Artificial Intelligence (AI) In Pharmaceutical Market

12.1. Asia-Pacific Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. Asia-Pacific Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. China Generative Artificial Intelligence (AI) In Pharmaceutical Market

13.1. China Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

13.2. China Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. India Generative Artificial Intelligence (AI) In Pharmaceutical Market

14.1. India Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Japan Generative Artificial Intelligence (AI) In Pharmaceutical Market

15.1. Japan Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

15.2. Japan Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Australia Generative Artificial Intelligence (AI) In Pharmaceutical Market

16.1. Australia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Indonesia Generative Artificial Intelligence (AI) In Pharmaceutical Market

17.1. Indonesia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. South Korea Generative Artificial Intelligence (AI) In Pharmaceutical Market

18.1. South Korea Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. South Korea Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Taiwan Generative Artificial Intelligence (AI) In Pharmaceutical Market

19.1. Taiwan Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. Taiwan Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. South East Asia Generative Artificial Intelligence (AI) In Pharmaceutical Market

20.1. South East Asia Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. South East Asia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Western Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market

21.1. Western Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

21.2. Western Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. UK Generative Artificial Intelligence (AI) In Pharmaceutical Market

22.1. UK Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. Germany Generative Artificial Intelligence (AI) In Pharmaceutical Market

23.1. Germany Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. France Generative Artificial Intelligence (AI) In Pharmaceutical Market

24.1. France Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Italy Generative Artificial Intelligence (AI) In Pharmaceutical Market

25.1. Italy Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Spain Generative Artificial Intelligence (AI) In Pharmaceutical Market

26.1. Spain Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Eastern Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market

27.1. Eastern Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

27.2. Eastern Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Russia Generative Artificial Intelligence (AI) In Pharmaceutical Market

28.1. Russia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. North America Generative Artificial Intelligence (AI) In Pharmaceutical Market

29.1. North America Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. North America Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. USA Generative Artificial Intelligence (AI) In Pharmaceutical Market

30.1. USA Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. USA Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. Canada Generative Artificial Intelligence (AI) In Pharmaceutical Market

31.1. Canada Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. Canada Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. South America Generative Artificial Intelligence (AI) In Pharmaceutical Market

32.1. South America Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

32.2. South America Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Brazil Generative Artificial Intelligence (AI) In Pharmaceutical Market

33.1. Brazil Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Middle East Generative Artificial Intelligence (AI) In Pharmaceutical Market

34.1. Middle East Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Middle East Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Africa Generative Artificial Intelligence (AI) In Pharmaceutical Market

35.1. Africa Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

35.2. Africa Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

36. Generative Artificial Intelligence (AI) In Pharmaceutical Market Regulatory and Investment Landscape

37. Generative Artificial Intelligence (AI) In Pharmaceutical Market Competitive Landscape And Company Profiles

37.1. Generative Artificial Intelligence (AI) In Pharmaceutical Market Competitive Landscape And Market Share 2024

37.1.1. Top 10 Companies (Ranked by revenue/share)

37.2. Generative Artificial Intelligence (AI) In Pharmaceutical Market - Company Scoring Matrix

37.2.1. Market Revenues

37.2.2. Product Innovation Score

37.2.3. Brand Recognition

37.3. Generative Artificial Intelligence (AI) In Pharmaceutical Market Company Profiles

37.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

37.3.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

37.3.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

37.3.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

37.3.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

38. Generative Artificial Intelligence (AI) In Pharmaceutical Market Other Major And Innovative Companies

Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Fujitsu Limited, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., NVIDIA Corporation, Conduent Incorporated, XtalPi Inc., Insilico Medicine Inc.

39. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market Competitive Benchmarking And Dashboard

40. Key Mergers And Acquisitions In The Generative Artificial Intelligence (AI) In Pharmaceutical Market

41. Generative Artificial Intelligence (AI) In Pharmaceutical Market High Potential Countries, Segments and Strategies

41.1. Generative Artificial Intelligence (AI) In Pharmaceutical Market In 2030 - Countries Offering Most New Opportunities

41.2. Generative Artificial Intelligence (AI) In Pharmaceutical Market In 2030 - Segments Offering Most New Opportunities

41.3. Generative Artificial Intelligence (AI) In Pharmaceutical Market In 2030 - Growth Strategies

41.3.1. Market Trend Based Strategies

41.3.2. Competitor Strategies

42. Appendix

42.1. Abbreviations

42.2. Currencies

42.3. Historic And Forecast Inflation Rates

42.4. Research Inquiries

42.5. The Business Research Company

42.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Overview Of Key Products - Product Examples
  • Table 2: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Supply Chain Analysis
  • Table 4: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Major Raw Material Providers
  • Table 5: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Major Resource Providers
  • Table 6: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Major Manufacturers (Suppliers)
  • Table 7: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Major Distributors And Channel Partners
  • Table 8: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Key Technologies & Future Trends
  • Table 9: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Major Trends
  • Table 10: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Major End Users
  • Table 11: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Generative Artificial Intelligence (AI) In Pharmaceutical Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Generative Artificial Intelligence (AI) In Pharmaceutical Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market - TAM, US$ Billion, 2025
  • Table 15: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Sub-Segmentation Of Small Molecule, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Sub-Segmentation Of Large Molecule, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Average Selling Price By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $
  • Table 21: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Average Spending Per Capita (Employed) By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $
  • Table 22: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Global Generative Artificial Intelligence (AI) In Pharmaceutical Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 97: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market - Company Scoring Matrix
  • Table 98: Pfizer Inc. Financial Performance
  • Table 99: Johnson & Johnson Financial Performance
  • Table 100: Roche Holding AG Financial Performance
  • Table 101: Merck & Co. Inc. Financial Performance
  • Table 102: AbbVie Inc. Financial Performance
  • Table 103: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Competitive Benchmarking (In USD Billions)
  • Table 104: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Competitive Dashboard
  • Table 105: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 106: Global, Generative Artificial Intelligence (AI) In Pharmaceutical Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 107: Global, Generative Artificial Intelligence (AI) In Pharmaceutical Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030
  • Table 108: Global, Generative Artificial Intelligence (AI) In Pharmaceutical Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

    Figure 1: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Supply Chain Analysis
  • Figure 4: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Major Raw Material Providers
  • Figure 5: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Major Resource Providers
  • Figure 6: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Major Distributors And Channel Partners
  • Figure 8: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Key Technologies & Future Trends
  • Figure 9: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Major Trends
  • Figure 10: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Major End Users
  • Figure 11: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Generative Artificial Intelligence (AI) In Pharmaceutical Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Generative Artificial Intelligence (AI) In Pharmaceutical Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market - TAM, US$ Billion, 2025
  • Figure 15: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Sub-Segmentation Of Small Molecule, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Sub-Segmentation Of Large Molecule, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Average Selling Price By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $
  • Figure 21: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Average Spending Per Capita (Employed) By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $
  • Figure 22: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Global Generative Artificial Intelligence (AI) In Pharmaceutical Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 97: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market - Company Scoring Matrix
  • Figure 98: Pfizer Inc. Financial Performance
  • Figure 99: Johnson & Johnson Financial Performance
  • Figure 100: Roche Holding AG Financial Performance
  • Figure 101: Merck & Co. Inc. Financial Performance
  • Figure 102: AbbVie Inc. Financial Performance
  • Figure 103: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Competitive Benchmarking (In USD Billions)
  • Figure 104: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Competitive Dashboard
  • Figure 105: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 106: Global, Generative Artificial Intelligence (AI) In Pharmaceutical Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 107: Global, Generative Artificial Intelligence (AI) In Pharmaceutical Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030
  • Figure 108: Global, Generative Artificial Intelligence (AI) In Pharmaceutical Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Top Growth Trends in the Airborne Telemetry Market: Insights into Market Size and Opportunities for 2025-2034

Read More About Top Growth Trends in the Airborne Telemetry Market: Insights into Market Size and Opportunities for 2025-2034

Generative AI In Gaming Market Report 2026 - Global Outlook – By Technique (Deterministic, Nondeterministic), By Function (Image Enhancement, Level Generation, Scenarios And Stories, Balancing In-Game Complexity, Non-Pla...

Generative AI Market Report 2026 - Global Outlook – By Component (Software, Services), By Offering Type (Image, Video, Speech, Other Offering Types), By Technology (Generative Adversarial Networks (GANs), Transformer, Va...

Generative Artificial Intelligence (AI) in Sports Market Report 2026 - Global Outlook – By Sports Type (Football, Tennis, Cricket, Basketball, Hockey, Golf, Other Sports), By Deployment (On-Premises, Cloud-Based), By App...

Generative Artificial Intelligence In Development And Operations (DevOps) Market Report 2026 - Global Outlook – By Component (Solutions, Services), By Deployment Mode (On-premise, Cloud-based), By Application (Testing, D...

Artificial Intelligence (AI) In Agriculture Market Report 2026 - Global Outlook – By Component (Hardware, Software, Services), By Technology (Machine Learning, Predictive Analysis, Computer Vision), By Deployment (Cloud,...

Artificial Intelligence (AI) In Respiratory Diseases Market Report 2026 - Global Outlook – By Imaging Type (Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO)), B...

Artificial Intelligence (AI) In Video Surveillance Market Report 2026 - Global Outlook – By Offering (Hardware, Software, Service), By Deployment Mode (On-Premises, Cloud-Based), By Use Cases (Gun Detection, Anomaly Dete...

Artificial Intelligence (AI) In Hospitality Market Report 2026 - Global Outlook – By Technology (Machine Learning, Natural Language Processing, Chatbots Or Travel Bots, Blockchain, Big Data, Other Technologies), By Hospi...

Frequently Asked Questions

The Generative Artificial Intelligence (AI) In Pharmaceutical market was valued at $2.43 billion in 2025, increased to $3.19 billion in 2026, and is projected to reach $9.36 billion by 2030.

The global Generative Artificial Intelligence (AI) In Pharmaceutical market is expected to grow at a CAGR of 30.9% from 2026 to 2035 to reach $9.36 billion by 2035.

Some Key Players in the Generative Artificial Intelligence (AI) In Pharmaceutical market Include, Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Fujitsu Limited, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., NVIDIA Corporation, Conduent Incorporated, XtalPi Inc., Insilico Medicine Inc., Numerate Inc., Atomwise Inc., BenevolentAI Limited .

Major trend in this market includes: Advancements In Drug Discovery With Generative AI. For further insights on this market. request a sample here

North America was the largest region in the generative artificial intelligence (AI) in the pharmaceutical market in 2025. The regions covered in the generative artificial intelligence (AI) in pharmaceutical market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us